...
首页> 外文期刊>Psychopharmacology >Randomized, double-blind, placebo-controlled, crossover study of the effects of repeated-dose caffeine on neurobehavioral performance during 48h of total sleep deprivation
【24h】

Randomized, double-blind, placebo-controlled, crossover study of the effects of repeated-dose caffeine on neurobehavioral performance during 48h of total sleep deprivation

机译:随机,双盲,安慰剂控制,交叉研究重复剂量咖啡因在总睡眠剥夺48H期间的神经兽性性能下

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

RationaleCaffeine is widely used as a countermeasure against neurobehavioral impairment during sleep deprivation. However, little is known about the pharmacodynamic profile of caffeine administered repeatedly during total sleep deprivation.ObjectivesTo investigate the effects of repeated caffeine dosing on neurobehavioral performance during sleep deprivation, we conducted a laboratory-based, randomized, double-blind, placebo-controlled, crossover, multi-dose study of repeated caffeine administration during 48h of sleep deprivation. Twelve healthy adults (mean age 27.4years, six women) completed an 18-consecutive-day in-laboratory study consisting of three 48h total sleep deprivation periods separated by 3-day recovery periods. During each sleep deprivation period, subjects were awakened at 07:00 and administered caffeine gum (0, 200, or 300mg) at 6, 18, 30, and 42h of wakefulness. The Psychomotor Vigilance Test and Karolinska Sleepiness Scale were administered every 2h.ResultsThe 200 and 300mg doses of caffeine mitigated neurobehavioral impairment across the sleep deprivation period, approaching two-fold performance improvements relative to placebo immediately after the nighttime gum administrations. No substantive differences were noted between the 200 mgand 300mg caffeine doses, and adverse effects were minimal.ConclusionsThe neurobehavioral effects of repeated caffeine dosing during sleep deprivation were most evident during the circadian alertness trough (i.e., at night). The difference between the 200mg and 300mg doses, in terms of the mitigation of performance impairment, was small. Neither caffeine dose fully restored performance to well-rested levels. These findings inform the development of biomathematical models that more accurately account for the time of day and sleep pressure-dependent effects of caffeine on neurobehavioral performance during sleep loss.
机译:睡眠剥夺期间,Rationalafafafeine广泛用作针对神经障碍损伤的对策。然而,关于在总睡眠剥夺期间反复施用的咖啡因的药效表曲线知之甚少。目的探讨反复咖啡因给药在睡眠剥夺期间对神经表现的影响,我们进行了实验室,随机,双盲,安慰剂控制,睡眠剥夺48H期间重复咖啡因施用的交叉,多剂量研究。 12位健康成年人(平均27.4年,六名妇女)完成了一项连续18天的实验室研究,由3日恢复期分开的三个48h总睡眠剥夺期。在每个睡眠剥夺期间,受试者在07:00唤醒,并在6,18,30和42小时施用咖啡因胶(0,200或300mg)。每2小时给药治疗精神摄像机治疗和Karolinska嗜睡量表。睡眠剥夺期间的200和300mg剂量减少的咖啡因,在夜间口香糖主管部门后立即接近与安慰剂的两倍性能改善。在200毫克300mg咖啡因剂量之间没有注意到实质性差异,并且不良反应是最小的。在恐怖症剥夺期间,在肠胃缺乏期间重复咖啡因给药的神经麻烦作用最明显(即,在晚上)。在减轻性能损伤方面,200mg和300mg剂量之间的差异很小。既不是咖啡因剂量完全恢复到休息良好的水平。这些调查结果为发展的生物肿瘤模型的发展提供了更准确地占咖啡因在睡眠损失期间咖啡因对神经表现性能的抑制作用。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号